Eli Lilly and Co (LLY)
805.11
-16.08
(-1.96%)
USD |
NYSE |
Jul 26, 16:00
804.60
-0.51
(-0.06%)
After-Hours: 20:00
Eli Lilly Price: 805.11 for July 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Jul 25, 2024 | 847.00 | 851.62 | 806.38 | 821.19 | 5.379M |
Jul 24, 2024 | 872.50 | 878.34 | 854.27 | 859.88 | 2.726M |
Jul 23, 2024 | 870.00 | 887.72 | 864.08 | 878.29 | 2.088M |
Jul 22, 2024 | 864.80 | 874.42 | 856.82 | 865.97 | 2.905M |
Jul 19, 2024 | 867.66 | 880.21 | 853.00 | 857.47 | 3.782M |
Jul 18, 2024 | 907.03 | 909.87 | 836.66 | 848.90 | 7.650M |
Jul 17, 2024 | 910.01 | 925.00 | 902.64 | 905.59 | 4.201M |
Jul 16, 2024 | 955.75 | 956.39 | 938.38 | 941.60 | 2.112M |
Jul 15, 2024 | 956.20 | 966.10 | 948.09 | 950.46 | 2.359M |
Jul 12, 2024 | 937.00 | 950.79 | 936.03 | 948.40 | 2.315M |
Jul 11, 2024 | 934.09 | 942.88 | 918.62 | 934.14 | 2.858M |
Jul 10, 2024 | 936.57 | 945.69 | 933.00 | 939.78 | 2.683M |
Jul 09, 2024 | 929.05 | 935.00 | 920.78 | 932.50 | 2.420M |
Jul 08, 2024 | 917.89 | 928.60 | 912.00 | 918.00 | 2.365M |
Jul 05, 2024 | 898.42 | 916.46 | 896.90 | 914.57 | 2.881M |
Jul 03, 2024 | 911.00 | 918.50 | 884.00 | 898.10 | 3.078M |
Jul 02, 2024 | 902.71 | 912.00 | 878.50 | 906.71 | 4.585M |
Jul 01, 2024 | 911.77 | 916.83 | 904.31 | 914.37 | 2.546M |
Jun 28, 2024 | 911.31 | 915.54 | 905.38 | 905.38 | 3.375M |
Jun 27, 2024 | 903.53 | 909.57 | 899.72 | 909.04 | 1.948M |
Jun 26, 2024 | 904.00 | 906.34 | 897.84 | 901.26 | 2.232M |
Jun 25, 2024 | 891.77 | 909.42 | 891.50 | 904.61 | 2.840M |
Jun 24, 2024 | 889.98 | 903.58 | 882.94 | 890.11 | 2.878M |
Jun 21, 2024 | 885.66 | 891.97 | 879.80 | 883.88 | 3.449M |
Jun 20, 2024 | 893.00 | 905.45 | 870.13 | 885.99 | 3.360M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
106.92
Minimum
Oct 10 2019
950.46
Maximum
Jul 15 2024
326.62
Average
263.46
Median
Price Benchmarks
Amgen Inc | 334.71 |
Biogen Inc | 211.01 |
Vertex Pharmaceuticals Inc | 495.20 |
Viking Therapeutics Inc | 65.87 |
Morphic Holding Inc | 56.54 |
Price Related Metrics
PE Ratio | 118.57 |
PS Ratio | 20.22 |
PEG Ratio | 12.22 |
Price to Book Value | 56.58 |
Earnings Yield | 0.84% |
Market Cap | 724.93B |
PEGY Ratio | 11.51 |
Operating PE Ratio | 60.35 |
Normalized PE Ratio | 78.54 |